Millennium Sues Wockhardt Over Generic Cancer Drug
Wockhardt has been accused of infringing two of Millennium Pharmaceutical Inc.'s patents for its cancer drug Velcade by seeking approval from the U.S. Food and Drug Administration to manufacture and sell...To view the full article, register now.
Already a subscriber? Click here to view full article